Search Results
Results found for "positive allosteric modulators"
- Can we preserve opioid pain relief without the side effects? 🔬 On Ep.166 of the Dr.GPCR Podcast, Ben Clements shares how positive allosteric modulators (PAMs) at the mu-opioid receptor could revolutionize treatment —with a 10x boost in methadone efficacy. Tune in for a masterclass on translational pharmacology, curiosity-driven science, and meaningful mentorship. 🎧 Full episode: Ep 166 with Dr. Ben Clements #GPCRresearch #DrGPCR #GPCRpodcast #OpioidPharmacology #DrugDiscovery | Dr. GPCR Ecosystem
🔬 On Ep.166 of the Dr.GPCR Podcast, Ben Clements shares how positive allosteric modulators (PAMs) at 🔬 On Ep.166 of the Dr.GPCR Podcast, Ben Clements shares how positive allosteric modulators (PAMs) at
- A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice
About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
GPCR scientist Ben Clements shares how positive allosteric modulators could transform opioid therapy allosteric modulators (PAMs) targeting opioid receptors. Allosteric Modulation: The New Frontier of GPCR Drug Discovery Ben reflects on the emerging potential “Allosteric modulation in GPCRs is so novel and so exciting. allosteric modulators of the mu-opioid receptor.
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
Since then, he has been studying the allosteric modulation and activation mechanism of this family of activation of cell surface receptors by intracellular proteins; the regulation of GPCRs by both negative and positive allosteric modulators, and the asymmetric functioning of GPCR dimers.
- Dr. Robert F. Bruns | Dr. GPCR Ecosystem
Bruns Fred Bruns discovered the first positive allosteric modulator (PAM) of a GPCR in the late 1980s
- 🚀 New Workshop: Practical Quantification of Allosteric Modulation Join Dr. Terry Kenakin on May 1st, 2025, for an advanced live workshop on allosteric modulators in GPCR drug discovery. Learn how to: ✔️ Identify, measure, and quantify allosteric properties ✔️ Apply functional allosteric models to determine mechanisms of action ✔️ Confirm allostery through kinetic analysis 📅 Date: May 1st, 2025 ⏳ Registration deadline: April 18th 📍 Live on Google Meet 🔗 Register now: https://www.ecosystem.drgpcr.com/event-details-registration/practical-quantification-of-allosteric-modulation #GPCR #Allostery #DrugDiscovery #Pharmacology | Dr. GPCR Ecosystem
Home → Flash News → 🚀 New Workshop: Practical Quantification of Allosteric Modulation Join Dr. Terry Kenakin on May 1st, 2025, for an advanced live workshop on allosteric modulators in GPCR drug discovery Register now: https://www.ecosystem.drgpcr.com/event-details-registration/practical-quantification-of-allosteric-modulation New Workshop: Practical Quantification of Allosteric Modulation Join Dr. Terry Kenakin on May 1st, 2025 , for an advanced live workshop on allosteric modulators in GPCR drug
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
GPCR Podcast Strategic Partners A Brief History of allosteric modulation with Dr. involving autoantibodies and allosteric modulators. model for allosteric modulation, emphasizing the balance between mechanism and empiricism. interactions, specifically allosteric modulation. and allosteric modulation in the context of disease and therapeutic approaches.
- Did you know? 🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! 🧬💡 These innovative compounds, “Photo-BQCisA” and “Photo-BQCtrAns,” offer subtype-selective precision by combining allosteric modulation with light control, paving the way for new therapeutic strategies targeting muscarinic receptors (M1-M5). 🔬✨ Learn more about this breakthrough in the Ecosystem! | Dr. GPCR Ecosystem
🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! innovative compounds, “Photo-BQCisA” and “Photo-BQCtrAns,” offer subtype-selective precision by combining allosteric modulation with light control, paving the way for new therapeutic strategies targeting muscarinic receptors 🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! “Photo-BQCtrAns,” offer subtype-selective precision by combining allosteric modulation with light control
- Do you know we can discover allosteric modulators that bind to the intracellular allosteric binding site to better fine-tune the GPCRs’ activity? Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine receptors CCR6 and CXCR1. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! | Dr. GPCR Ecosystem
Home → Flash News → Do you know we can discover allosteric modulators that bind to the intracellular allosteric binding site to better fine-tune the GPCRs’ activity? Published on October 29, 2024 Category GPCR Weekly News Do you know we can discover allosteric modulators that bind to the intracellular allosteric binding site to better fine-tune the GPCRs’ activity?
- Did you know allosteric modulators can change the GPCR G protein subtype selectivity? Have a look at this study to dive deep into its molecular mechanism. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox. | Dr. GPCR Ecosystem
Home → Flash News → Did you know allosteric modulators can change the GPCR G protein subtype selectivity Published on December 12, 2024 Category GPCR Weekly News Did you know allosteric modulators can change delivered to your inbox. ➡ https:// www.ecosystem.drgpcr.com/gpcr-binders-drugs-and-more/design-of-allosteric-modulators-that-change-gpcr-g-protein-subtype-selectivity
- Illuminating Functional Selectivity and Allosterism at GPCRs.
Committee Sponsors GPCR Retreat Program < Back to schedule Illuminating Functional Selectivity and Allosterism His research program also studies the allosteric, biased signalling regulation of GPCR and has contributed
- Complex Allosteric Cannabinoid Receptor Pharmacology
Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Complex Allosteric
- Unlock your pharmacology potential with Terry’s Corner. No fluff. Just clear, on-demand insight from Dr. Terry Kenakin—built for scientists at every level. 🟢 Building core expertise? Learn dose-response, agonism, binding, bias, kinetics, and the models that build real confidence. 🟢 Driving drug discovery? Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug hunter? Sharpen your edge with allosteric modulation, residence time, molecular dynamics, and translational PK/PD. Learn on-demand. Apply immediately. Early access begins July 1 → https://www.terrykenakin.com #pharmacology #GPCRscience #drugdiscovery #TerrysCorner #biotechtraining | Dr. GPCR Ecosystem
Learn dose-response, agonism, binding, bias, kinetics, and the models that build real confidence. 🟢 Sharpen your edge with allosteric modulation, residence time, molecular dynamics, and translational PK Learn dose-response, agonism, binding, bias, kinetics, and the models that build real confidence. 🟢 Sharpen your edge with allosteric modulation, residence time, molecular dynamics, and translational PK
- A large-scale analysis of GPCR molecular dynamics reveals hidden allosteric sites and lateral gateways, unlocking new possibilities for drug discovery. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function/large-scale-investigation-of-gpcr-molecular-dynamics-data-uncovers-allosteric-sites-and-lateral-gateways #gpcr#drgpcr | Dr. GPCR Ecosystem
Home → Flash News → A large-scale analysis of GPCR molecular dynamics reveals hidden allosteric sites structural-and-molecular-insights-into-gpcr-function/large-scale-investigation-of-gpcr-molecular-dynamics-data-uncovers-allosteric-sites-and-lateral-gateways 17, 2025 Category GPCR Weekly News A large-scale analysis of GPCR molecular dynamics reveals hidden allosteric structural-and-molecular-insights-into-gpcr-function/large-scale-investigation-of-gpcr-molecular-dynamics-data-uncovers-allosteric-sites-and-lateral-gateways
- ama session sept 18 post 1 | Dr. GPCR Ecosystem
Join Terry’s Corner AMA to master GPCR signaling, allosteric modulation, and kinetic strategy in drug Home → Flash News → ama session sept 18 post 1 Ask-Me-Anything Session - Sept 18 - Trailer Published In the discovery phase, one overlooked kinetic parameter or a misjudged model can set your team back session, you’ll learn how to: Decode GPCR signaling complexity using functional assay strategies Identify allosteric modulators before they derail downstream decisions Integrate kinetics early—before your program locks
- Weekly News October 16 | Dr. GPCR Ecosystem
Explore inhibition modes, CYP450 allostery, and insights from Dr. unpack inhibition modes (competitive, noncompetitive, mixed, uncompetitive), the messy truth of CYP450 allostery and DDIs, and why allosteric control can protect potency in substrate-rich environments.
- 10 GPCR pharmacology lessons. Zero fluff. Launching July 1, Terry’s Corner gives you the clarity and confidence to make better decisions—starting with: • The role of pharmacology in discovery strategy • Black & Leff’s operational model—finally made practical • Binding curves, orthosteric vs allosteric function, and real vs apparent affinity • Molecular dynamics and how they guide ligand design • Why Terry built this—and how it sharpens your next move 📅 Learn anytime. New course every week. 📬 Subscribe to The Kenakin Brief → https://www.terrykenakin.com #GPCRscience #drugdiscovery #TerrysCorner #GPCRpharmacology #ligandbinding | Dr. GPCR Ecosystem
decisions—starting with: • The role of pharmacology in discovery strategy • Black & Leff’s operational model—finally made practical • Binding curves, orthosteric vs allosteric function, and real vs apparent affinity • decisions—starting with: 🟢 The role of pharmacology in discovery strategy 🟢 Black & Leff’s operational model—finally made practical 🟢 Binding curves, orthosteric vs allosteric function, and real vs apparent affinity
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor neuroscience approaches, the Slosky Lab is now working to understand how the principles of receptor allosterism
- Brendan Wilkins | Dr. GPCR Ecosystem
In his Honours year, Brendan explored small molecule allosteric modulators of the β2-adrenoceptor under Brendan is currently looking for post-doctoral positions to begin in mid-2024" Brendan Wilkins on the
- This new study reveals how the conformation of parathyroid hormone (PTH) and the C-terminal helix α5 of Gα regulate the selective coupling of PTH1R to Gs or Gq. Through Cryo-EM and single-cell experiments, the authors show differences in binding affinity, duration, and strength. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️ https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function/allosteric-mechanism-in-the-distinctive-coupling-of-gq-and-gs-to-the-parathyroid-hormone-type-1-receptor #gpcr #drgpcr | Dr. GPCR Ecosystem
your inbox ➡️ https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function/allosteric-mechanism-in-the-distinctive-coupling-of-gq-and-gs-to-the-parathyroid-hormone-type your inbox ➡️ https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function/allosteric-mechanism-in-the-distinctive-coupling-of-gq-and-gs-to-the-parathyroid-hormone-type
- GPCR Courses
Modulators Terry Kenakin 🔒 Premium Content Watch recording Advanced data analysis for GPCR pharmacology Class 3 - Antagonist pharmacology and binding assay analysis Class 4 - New dimensions of activity: Allosteric modulators and kinetics Sam Hoar 🔒 Premium Content Watch recording Principles of Pharmacology in Drug Modulators: NAMs, PAMs, Special Properties, Methods to quantify the allosteric effect Terry Kenakin modulation & kinetics, advanced quantitative approaches and innovation & strategic application Can I
- terrys corner no fluff pure insight | Dr. GPCR Ecosystem
Push the boundaries with advanced concepts like allosteric modulation and residence time?
- Terry's Corner is Officially LIVE! 🎉 This is your new go-to for mastering drug discovery pharmacology. No fluff, just clear, on-demand insights from Terry Kenakin. Building core expertise? Master dose-response, binding, kinetics, and foundational models. Driving drug discovery? Apply pharmacology to selectivity, ADME, and strategic decision-making. An experienced drug hunter? Sharpen your edge with allosteric bias, residence time, and translational PK/PD. Learn on-demand, apply immediately: https://terrykenakin.com #DrGPCR #GPCR #pharmacology #TerrysCorner #DrugDiscovery | Dr. GPCR Ecosystem
Master dose-response, binding, kinetics, and foundational models. Driving drug discovery? Sharpen your edge with allosteric bias, residence time, and translational PK/PD. Master dose-response, binding, kinetics, and foundational models. Driving drug discovery? Sharpen your edge with allosteric bias, residence time, and translational PK/PD. But in Melbourne, a quiet experiment challenged that model — and it worked. Dr.
- Dr. Prasenjit Saha | Dr. GPCR Ecosystem
During my post-doctoral research, I was part of a study that identified the receptors of a novel human More recently, I have shifted my focus to identifying allosteric modulators of host G-protein-coupled However, the pursuit of allosteric modulators has gained attention as they have the potential to fine-tune
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
steroidogenesis in regulating sexual determination and adrenal and gonadal development using genetic mouse models Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor neuroscience approaches, the Slosky Lab is now working to understand how the principles of receptor allosterism
- Dr. Mark Connor | Dr. GPCR Ecosystem
Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons Interested in orthosteric and allosteric interactions, and still looking for some bias ... anywhere .
- U - Landing Page | Dr. GPCR Ecosystem
Allosteric Modulation & Kinetics Step beyond orthosteric drugs and uncover the power of allosteric modulators track including but not limited to p harmacology foundations, agonists, antagonists & core mechanisms , allosteric modulation & kinetics, advanced quantitative approaches and innovation & strategic application Can I
- Dr. Kathryn E Livingston | Dr. GPCR Ecosystem
John Traynor , Kathryn worked to develop and understand first-in-class allosteric modulators of opioid Following this, Kathryn did a post-doctoral fellowship at UCSF in the laboratory of Dr.
- Interrogating Multiscale Receptors Functions in Space
Beaulieu received a Ph.D. in Neurological Sciences from McGill University and completed his post-doctoral The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric modulators of D2R signaling and explores the potential usefulness of beta-arrestins for the development Translational validation is important to validate findings obtained from experimental models research
- Dr. Samuel Hoare | Dr. GPCR Ecosystem
Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors
















